salmeterol xinafoate has been researched along with Lung Diseases, Obstructive in 2 studies
salmeterol : A racemate consisting of equal parts of (R)- and (S)-salmeterol. It is a potent and selective beta2-adrenoceptor agonist (EC50 = 5.3 nM). Unlike other beta2 agonists, it binds to the exo-site domain of beta2 receptors, producing a slow onset of action and prolonged activation.
2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol : A phenol having a hydroxymethyl group at C-2 and a 1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl group at C-4; derivative of phenylethanolamine.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnert, RV | 1 |
| Brown, RC | 1 |
| Chapman, D | 1 |
| Cheshire, DR | 1 |
| Dixon, J | 1 |
| Ince, F | 1 |
| Kinchin, EC | 1 |
| Lyons, AJ | 1 |
| Davis, AM | 1 |
| Hallam, C | 1 |
| Harper, ST | 1 |
| Unitt, JF | 1 |
| Dougall, IG | 1 |
| Jackson, DM | 1 |
| McKechnie, K | 1 |
| Young, A | 1 |
| Simpson, WT | 1 |
| Jacobsen, JR | 1 |
| Aggen, JB | 1 |
| Church, TJ | 1 |
| Klein, U | 1 |
| Pfeiffer, JW | 1 |
| Pulido-Rios, TM | 1 |
| Thomas, GR | 1 |
| Yu, C | 1 |
| Moran, EJ | 1 |
2 other studies available for salmeterol xinafoate and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Anti-Asthmatic Agents; Bronc | 1998 |
Multivalent design of long-acting β(2)-adrenoceptor agonists incorporating biarylamines.
Topics: Adrenergic beta-2 Receptor Agonists; Amines; Animals; Disease Models, Animal; Dose-Response Relation | 2014 |